Global Pharma Guidance Tracker – Test sabbah

Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

Global Guidance Tracker regular Column Feature image

Click on the links to access the documents that have been added to the Pink Sheet’s Guidance Tracker over the past month. The complete Global Pharma Guidance Tracker with sortable and searchable listings going back to 2014 is available here.

Key:

WHO: World Health Organization

ICH: International Council for Harmonisation

TGA: Therapeutic Goods Administration

HC: Health Canada

DMA: Danish Medicines Agency

EDA: Egyptian Drug Authority

EMA: European Medicines Agency

FDA Ghana: Food and Drugs Authority Ghana

CDSCO: Central Drugs Standard Control Organization

DoP: Department of Pharmaceuticals

AIFA: Italian Medicines Agency

PMDA: Pharmaceuticals and Medical Devices Agency

NPRA: National Pharmaceutical Regulatory Agency

CCMO: Central Committee on Research Involving Human Subjects

Medsafe: Medicines and Medical Devices Safety Authority

NAFDAC: National Agency for Food & Drug Administration & Control

DRAP: Drug Regulatory Authority of Pakistan

FDA Philippines: Food and Drug Administration Philippines

Saudi FDA: Saudi Food & Drug Authority

HSA: Health Sciences Authority

SAHPRA: South African Health Products Regulatory Authority

Swissmedic: Swiss Agency for Therapeutic Products

MHRA: Medicines and Healthcare products Regulatory Agency

FDA: Food and Drug Administration

Editor’s note: We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in the topic areas, the coverage format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard. The survey should only take seven minutes to complete, and you get the chance to win an Amazon gift voucher just by taking part. The deadline for responses is 17 September. Take the survey. Thank you!

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pink Sheet

Pink Sheet Podcast: Understanding the US FDA’s CDER Leadership - Clone

 

Pink Sheet reporter and editors discuss the likely impacts of Center for Drug Evaluation and Research Director Richard Pazdur’s retirement from the FDA and Tracy Beth Høeg becoming the center’s acting director.

Test FDA Voucher Program Approvals Will Come From Product Centers, But Ambiguity Lingers - Clone

 
• By 

Approval decisions for the FDA's CNPV pilot program will be made by product center officials, but it's unclear if the responsibility lies with center directors or review office leaders.

Pink Sheet Podcast: Understanding the US FDA’s CDER Leadership

 

Pink Sheet reporter and editors discuss the likely impacts of Center for Drug Evaluation and Research Director Richard Pazdur’s retirement from the FDA and Tracy Beth Høeg becoming the center’s acting director.

Test FDA Voucher Program Approvals Will Come From Product Centers, But Ambiguity Lingers

 
• By 

It is unclear in a revised staff manual guide whether Commissioner's National Priority Voucher program approval “recommendations” from the drug and biologic center directors will be advisory or decisional, experts told the Pink Sheet.

More from